Cytogenetic profile of 1791 adult acute myeloid leukemia in India

[1] Vardiman JW(2002)The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2292-2302

[2] Harris NL(2009)The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 937-951

[3] Brunning RD(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-2405

[4] Vardiman JW(2022)International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Blood 140 1200-1228

[5] Thiele J(2022)Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Blood 140 1345-1377

[6] Arber DA(2002)Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 4325-4336

[7] Brunning RD(2010)Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 354-365

[8] Borowitz MJ(2009)Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China Leukemia 23 1801-1806

[9] Porwit A(2005)Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients Ann Hematol 84 785-791

[10] Arber DA(2006)Population-Based Demographic Study of Karyotypes in 1709 Patients with Adult Acute Myeloid Leukemia Leukemia 20 444-450

[1] Vardiman JW(2002)The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2292-2302

[2] Harris NL(2009)The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 937-951

[3] Brunning RD(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-2405

[4] Vardiman JW(2022)International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Blood 140 1200-1228

[5] Thiele J(2022)Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Blood 140 1345-1377

[6] Arber DA(2002)Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 4325-4336

[7] Brunning RD(2010)Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 354-365

[8] Borowitz MJ(2009)Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China Leukemia 23 1801-1806

[9] Porwit A(2005)Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients Ann Hematol 84 785-791

[10] Arber DA(2006)Population-Based Demographic Study of Karyotypes in 1709 Patients with Adult Acute Myeloid Leukemia Leukemia 20 444-450